Aga Khan University
Karachi, Sindh, 74800, Pakistan
NCT Number: NCT06726057
This is a research about cardiovascular disease risk reduction: a comprehensive package for the reduction of risk in Sindh, Pakistan. The research is being conducted by the Aga Khan University and is funded by the National Institute of Health and Care Research UK.
Hypertension is a major public health concern globally. It is a significant risk for cardiovascular disease (CVD) and premature death. In Pakistan, the prevalence of hypertension, including those on medication, is high. However, there are also high rates of undertreatment and underdiagnosis of hypertension in Pakistan. Addressing the prevention and control of CVD requires a multi-faceted approach that targets diverse populations across different settings. In some populations, we have interventions that have been proven effective but have not been implemented for example in rural communities. In Pakistan, prior community-based trial regarding multi-component hypertension intervention has proven to be effective in reducing blood pressure. However, the findings of this work have not translated to change in practice on the ground suggesting the need for implementation research to examine the best ways to implement this intervention in the real world. Hence, in this study researchers aim to assess the impact of this evidence-based intervention when implemented at scale in rural communities.
Participants will be asked to participate in a research study designed to improve their blood pressure control. This study enrols participants aged 35 years and above. As part of this study, they will undergo:
* blood pressure measurements at regular intervals by lady health workers * home health education sessions conducted by lady health workers * participants may be referred to a nearby health facility/qualified medical practitioners for management of high blood pressure * baseline survey at the start of the study having questions about participants' medical history, risk factors for cardiovascular disease and high blood pressure and bodily measurements including weight, height and waist circumference * follow-up surveys every 6 months for 2 years. The survey questions will comprise of medical history, risk factors for cardiovascular disease and high blood pressure; and bodily measurements including weight, height and waist circumference * blood and urine samples for testing at baseline survey and during endline survey
POSSIBLE RISKS OR DISCOMFORT
There are no risks involved as a result of participants' participation in this study except for their time. Since they will be followed up for 2 years, any new information developed during the study that may affect their willingness to continue participation will be communicated to them. Participants may feel a little discomfort at the site of the needle prick when drawing a blood sample.
POSSIBLE BENEFITS
Participants will be able to know about their risk of high blood pressure and cardiovascular disease. They'll be referred to a qualified medical practitioner for the management of your high blood pressure. Also, the results of their blood and urine tests will be shared with participants that will help them know about their health.
The main contact for this research study is the principal investigator Dr Zainab Samad (02134864660).
This study is active but is not currently recruiting participants.
35 year and older
All sexes
Interventional
Not applicable
Karachi, Sindh, 74800, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this study, the researchers will develop and test strategies for the implementation and scale-up of a proven multicomponent hypertension intervention (MCHI) programme in Pakistan. Implementation strategies will be devised through an engagement process and will involve the use of implementation frameworks including the Consolidated Framework for Implementation Research (CFIR) to identify barriers and facilitators to the implementation of MCHI& Expert Recommendations for Implementation Change (ERIC) to identify a set of implementation strategies addressing each barrier. Input for the development of strategies will be sought from the community, public health sector managers, general practitioners and community health workers. The implementation strategies will be used to randomise study clusters while MCHI will be implemented in both intervention and control arms.
The multicomponent hypertension intervention has four components as follows:
Time frame: From enrollment to the end of Intervention at 24 months
After estimating the proportional change in the number between the baseline and the 24-month follow-up, the mean difference between both the study arms will be estimated. A mean difference of 0.1 would be considered clinically significant.
Time frame: From enrollment to the first 12 months of Intervention
The proportion of LHWs from 30 study clusters conducting HHE sessions, monitoring blood pressure and doing referrals of hypertensive patients to health facilities during the first 12 months Data source: HHE and referral checklists by LHWs, Baseline/follow-up survey
Time frame: From enrollment to the first 12 months of Intervention
The proportion of GPs from 30 study clusters screening and providing hypertension management to hypertensive patients at BHU/RHC referred by LHW during the first 12 months Data source: GP checklists, Baseline/follow-up surveys
Time frame: From enrollment to the end of Intervention at 24 months
The mean number of the planned home visits/participant over 24 months (a maximum of sixteen visits, one every 3 months, are planned per participant) by LHW for HHE and BP monitoring Data source: LHWs' HHE and referral checklists, Baseline/follow-up surveys
Time frame: From enrollment to the end of Intervention at 24 months
The mean number of healthcare contacts with GPs at the Basic Health Unit per participant over 24 months among those identified as having uncontrolled BP (SBP≥140 mm Hg and/or DBP≥90 mm Hg) by LHW at one or more than one occasion during the trial Data source: GP checklists, Baseline/follow-up surveys
Time frame: From enrollment to the end of Intervention at 24 months
The proportion of participants receiving visits by LHWs for HHE and BP monitoring at 6, 12, and 24 months.
Data source: LHWs' HHE & referral checklists, Baseline/follow-up surveys
Time frame: From enrollment to the end of Intervention at 24 months
The proportion of participants that received advice and/or treatment from the GPs at the Basic Health Unit after being identified as having uncontrolled BP (SBP≥140 mm Hg and/or DBP≥90 mm Hg) by LHW at 6, 12, and 24 months.
Data source: GP checklists, Baseline/follow-up surveys
Time frame: From enrollment to the end of Intervention at 24 months
Health-related quality of life i.e., EQ-5D-5L range, 0 to 100, with higher scores indicating better health.
Time frame: From enrollment to the end of Intervention at 24 months
The proportion of participants with blood-pressure control (SBP 140 mmHg and DBP 90 mmHg)
Aga Khan University
Other
A Multi-component Intervention for Controlling Hypertension in the Adult Rural Population of Pakistan: a Protocol for a Hybrid Type III Implementation-effectiveness Cluster Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07074145
Adherence Interventions, Behavior
Albuquerque, New Mexico, United States
View Trial DetailsNCT07045363
Adherence Interventions, Behavior
Suzhou, Jiangsu, China
View Trial DetailsNCT04197401
Adherence Interventions, Behavior
Al Matlīn, Bizerte Governorate, Tunisia
View Trial DetailsNCT02981251
Adherence Interventions, Behavior
Surkhet, Birendranagar Municipality, Nepal
View Trial Details